The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Apolipoprotein E but Not B Is Required for the Formation of Infectious Hepatitis C Virus Particles
Open accessAbstract
Our previous studies have found that hepatitis C virus (HCV) particles are enriched in apolipoprotein E (apoE) and that apoE is required for HCV infectivity and production. Studies by others, however, suggested that both microsomal transfer protein (MTP) and apoB are important for HCV production. To define the roles of apoB and apoE in the HCV life cycle, we developed a single-cycle HCV growth assay to determine the correlation of HCV assembly with apoB and apoE expression, as well as the influence of MTP inhibitors on the formation of HCV particles. The small interfering RNA (siRNA)-mediated knockdown of apoE expression remarkably suppressed the formation of HCV particles. However, apoE expressed ectopically could restore the defect of HCV production posed by the siRNA-mediated knockdown of endogenous apoE expression. In contrast, apoB-specific antibodies and siRNAs had no significant effect on HCV infectivity and production, respectively, suggesting that apoB does not play a significant role in the HCV life cycle. Additionally, two MTP inhibitors, CP-346086 and BMS-2101038, efficiently blocked secretion of apoB-containing lipoproteins but did not affect HCV production unless apoE expression and secretion were inhibited. At higher concentrations, however, MTP inhibitors blocked apoE expression and secretion and consequently suppressed the formation of HCV particles. Furthermore, apoE was found to be sensitive to trypsin digestion and to interact with NS5A in purified HCV particles and HCV-infected cells, as demonstrated by coimmunoprecipitation. Collectively, these findings demonstrate that apoE but not apoB is required for HCV assembly, probably via a specific interaction with NS5A.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989) · Science · doi:10.1126/science.2523562 · Cited by 6,875
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,029
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Surveillance for waterborne-disease outbreaks--United States, 1993-1994.
Kramer, M. H., Herwaldt, B. L., Craun, G. F., Calderon, R. L., & Juranek, D. D. (1996) · PubMed · Cited by 2,152
Efficient Initiation of HCV RNA Replication in Cell Culture
Blight, K. J., Kolykhalov, A. A., & Rice, C. M. (2000) · Science · doi:10.1126/science.290.5498.1972 · Cited by 1,412
(1998) · PsycEXTRA Dataset · doi:10.1037/e547602006-001 · Cited by 1,213
Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication
Blight, K. J., McKeating, J. A., & Rice, C. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.13001-13014.2002 · Cited by 1,193
Epidemiology of viral hepatitis and HIV co-infection
Alter, M. J. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.004 · Cited by 1,012
Unravelling hepatitis C virus replication from genome to function
Lindenbach, B. D., & Rice, C. M. (2005) · Nature · doi:10.1038/nature04077 · Cited by 820
Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles
André, P., Komurian-Pradel, F., Deforges, S., Perret, M., Berland, J. L., Sodoyer, M., Pol, S., Bréchot, C., Paranhos-Baccalà, G., & Lotteau, V. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.6919-6928.2002 · Cited by 690
Huang, H., Sun, F., Owen, D. M., Li, W., Chen, Y., Gale, M., & Ye, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700760104 · Cited by 533
Appel, N., Zayas, M., Miller, S., Krijnse-Locker, J., Schaller, T., Friebe, P., Kallis, S., Engel, U., & Bartenschlager, R. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000035 · Cited by 466
Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion
Gastaminza, P., Cheng, G., Wieland, S., Zhong, J., Liao, W., & Chisari, F. V. (2008) · Journal of Virology · doi:10.1128/jvi.02053-07 · Cited by 463
Fisher, E. A., & Ginsberg, H. N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100068200 · Cited by 460
Chang, K.-S., Jiang, J., Cai, Z., & Luo, G. (2007) · Journal of Virology · doi:10.1128/jvi.01091-07 · Cited by 424
Self-citationAssociation of hepatitis C virus in human sera with ?-lipoprotein
Thomssen, R., Bonk, S., Propfe, C., Heermann, K.-H., K�chel, H. G., & Uy, A. (1992) · Medical Microbiology and Immunology · doi:10.1007/bf00198849 · Cited by 366
Nielsen, S. U., Bassendine, M. F., Burt, A. D., Martin, C., Pumeechockchai, W., & Toms, G. L. (2006) · Journal of Virology · doi:10.1128/jvi.80.5.2418-2428.2006 · Cited by 347
Evans, M. J., Rice, C. M., & Goff, S. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405152101 · Cited by 339
Morrow, J. A., Segall, M. L., Lund-Katz, S., Phillips, M. C., Knapp, M., Rupp, B., & Weisgraber, K. H. (2000) · Biochemistry · doi:10.1021/bi000099m · Cited by 315
Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains.
Wetterau, J. R., Aggerbeck, L. P., Rall, S. C., & Weisgraber, K. H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68778-2 · Cited by 293
Virion Proteins of Kaposi's Sarcoma-Associated Herpesvirus
Zhu, F. X., Chong, J. M., Wu, L., & Yuan, Y. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.800-811.2005 · Cited by 269
An MTP Inhibitor That Normalizes Atherogenic Lipoprotein Levels in WHHL Rabbits
Wetterau, J. R., Gregg, R. E., Harrity, T. W., Arbeeny, C., Cap, M., Connolly, F., Chu, C.-H., George, R. J., Gordon, D. A., Jamil, H., et al. (1998) · Science · doi:10.1126/science.282.5389.751 · Cited by 267
Gastaminza, P., Kapadia, S. B., & Chisari, F. V. (2006) · Journal of Virology · doi:10.1128/jvi.01150-06 · Cited by 241
Hepatitis C Virus Particles and Lipoprotein Metabolism
André, P., Perlemuter, G., Budkowska, A., Bréchot, C., & Lotteau, V. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-864785 · Cited by 180
Chandler, C. E., Wilder, D. E., Pettini, J. L., Savoy, Y. E., Petras, S. F., Chang, G., Vincent, J., & Harwood, H. J. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300094-jlr200 · Cited by 177
Apolipoprotein C1 Association with Hepatitis C Virus
Meunier, J., Russell, R. S., Engle, R. E., Faulk, K. N., Purcell, R. H., & Emerson, S. U. (2008) · Journal of Virology · doi:10.1128/jvi.00914-08 · Cited by 168
El‐Hage, N., & Luo, G. G. (2003) · Journal of General Virology · doi:10.1099/vir.0.19305-0 · Cited by 135
Self-citationOxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells
von Hahn, T., Lindenbach, B. D., Boullier, A., Quehenberger, O., Paulson, M. S., Rice, C. M., & McKeating, J. A. (2006) · Hepatology · doi:10.1002/hep.21139 · Cited by 134
Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.
Krul, E. S., Tikkanen, M. J., Cole, T. G., Davie, J. M., & Schonfeld, G. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111708 · Cited by 111
The Exchangeable Apolipoprotein ApoC-I Promotes Membrane Fusion of Hepatitis C Virus
Dreux, M., Boson, B., Ricard‐Blum, S., Molle, J., Lavillette, D., Bartosch, B., Pécheur, E., & Cosset, F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705358200 · Cited by 104
Voisset, C., Beeck, A. O. D., Horellou, P., et al. (2006) · Journal of General Virology · doi:10.1099/vir.0.81932-0 · Cited by 102
Microsomal triglyceride transfer protein a multifunctional protein
Hussain, M. M., Iqbal, J., Anwar, K., Rava, P., & Dai, K. (2003) · Frontiers in bioscience · doi:10.2741/1071 · Cited by 94
Effect of Arginine 172 on the Binding of Apolipoprotein E to the Low Density Lipoprotein Receptor
Morrow, J. A., Arnold, K. S., Dong, J., Balestra, M. E., Innerarity, T. L., & Weisgraber, K. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2576 · Cited by 76
Impaired secretion of apolipoprotein E2 from macrophages
Fan, D., Qiu, S., Overton, C. D., Yancey, P. G., Swift, L. L., Jerome, W. G., Linton, M. F., & Fazio, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611754200 · Cited by 27 · cited 2×
“However, it did not significantly affect apoE secretion, consistent with a recent report that an MTP inhibitor completely blocked apoB but did not affect apoE secretion (16).”
Result
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
Scheel, T. K. H., & Rice, C. M. (2013) · Nature Medicine · doi:10.1038/nm.3248 · Cited by 554
A TALEN Genome-Editing System for Generating Human Stem Cell-Based Disease Models
Ding, Q., Lee, Y.-K., Schaefer, E. A. K., Peters, D. T., Veres, A., Kim, K., Kuperwasser, N., Motola, D. L., Meissner, T. B., Hendriks, W. T., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.11.011 · Cited by 501
Assembly of infectious hepatitis C virus particles
Bartenschlager, R., Penin, F., Lohmann, V., & André, P. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2010.11.005 · Cited by 453
The ins and outs of hepatitis C virus entry and assembly
Lindenbach, B. D., & Rice, C. M. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3098 · Cited by 387
Metadata
- Authors
- Jiang, J., & Luo, G.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2009-12-15
- Volume
- 83
- Issue
- 24
- Pages
- 12680-12691
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2084858225
- Cited by
- 255
- References
- 36
- FWCI
- 15.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.